249 related articles for article (PubMed ID: 31450489)
1. Sputum long non-coding RNA biomarkers for diagnosis of lung cancer.
Gupta C; Su J; Zhan M; Stass SA; Jiang F
Cancer Biomark; 2019; 26(2):219-227. PubMed ID: 31450489
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
Liao J; Shen J; Leng Q; Qin M; Zhan M; Jiang F
Thorac Cancer; 2020 Mar; 11(3):762-768. PubMed ID: 31994346
[TBL] [Abstract][Full Text] [Related]
3. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers.
Yu L; Todd NW; Xing L; Xie Y; Zhang H; Liu Z; Fang H; Zhang J; Katz RL; Jiang F
Int J Cancer; 2010 Dec; 127(12):2870-8. PubMed ID: 21351266
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA SNHG1 regulates zinc finger E-box binding homeobox 1 expression by interacting with TAp63 and promotes cell metastasis and invasion in Lung squamous cell carcinoma.
Zhang HY; Yang W; Zheng FS; Wang YB; Lu JB
Biomed Pharmacother; 2017 Jun; 90():650-658. PubMed ID: 28415044
[TBL] [Abstract][Full Text] [Related]
5. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
6. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
10. A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma.
Liao M; Liu Q; Li B; Liao W; Xie W; Zhang Y
Cancer Sci; 2018 Dec; 109(12):4033-4044. PubMed ID: 30290038
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA VPS9D1-AS1 overexpression predicts a poor prognosis in non-small cell lung cancer.
Tan J; Yang L
Biomed Pharmacother; 2018 Oct; 106():1600-1606. PubMed ID: 30119235
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma.
Zheng S; Zheng D; Dong C; Jiang J; Xie J; Sun Y; Chen H
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1649-1657. PubMed ID: 28409273
[TBL] [Abstract][Full Text] [Related]
13. Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis.
Su J; Liao J; Gao L; Shen J; Guarnera MA; Zhan M; Fang H; Stass SA; Jiang F
Oncotarget; 2016 Feb; 7(5):5131-42. PubMed ID: 26246471
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NEAT1 polymorphisms and lung cancer susceptibility in a Chinese Northeast Han Population: A case-control study.
Wang S; Cui Z; Li H; Li J; Lv X; Yang Z; Gao M; Bi Y; Zhang Z; Zhou B; Yin Z
Pathol Res Pract; 2019 Dec; 215(12):152723. PubMed ID: 31704150
[TBL] [Abstract][Full Text] [Related]
15. Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs.
Wang P; Lu S; Mao H; Bai Y; Ma T; Cheng Z; Zhang H; Jin Q; Zhao J; Mao H
Lung Cancer; 2015 May; 88(2):147-53. PubMed ID: 25758555
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of long noncoding RNA biomarkers in human non-small-cell lung carcinomas.
Yu H; Xu Q; Liu F; Ye X; Wang J; Meng X
J Thorac Oncol; 2015 Apr; 10(4):645-54. PubMed ID: 25590602
[TBL] [Abstract][Full Text] [Related]
17. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
18. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma.
Zhou M; Xu W; Yue X; Zhao H; Wang Z; Shi H; Cheng L; Sun J
Oncotarget; 2016 May; 7(20):29720-38. PubMed ID: 27105492
[TBL] [Abstract][Full Text] [Related]
19. The miRNA hsa-miR-6515-3p potentially contributes to lncRNA H19-mediated-lung cancer metastasis.
Xu Y; Lin J; Jin Y; Chen M; Zheng H; Feng J
J Cell Biochem; 2019 Oct; 120(10):17413-17421. PubMed ID: 31131469
[TBL] [Abstract][Full Text] [Related]
20. Untangling the evolutionary roots of lung cancer.
Devarakonda S; Govindan R
Nat Commun; 2019 Jul; 10(1):2979. PubMed ID: 31278259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
